Skip to main content
SpringerLink
Log in

Dementia

  • Chapter
Handbook of Clinical Nutrition and Aging

Part of the book series: Nutrition and Health ((NH))

Abstract

Dementia is a progressive decline in memory and other cognitive functions that results in functional impairment. Alzheimer’s disease (AD) is the most common, best-characterized, and most extensively studied cause of dementia. Although weight loss and malnutrition is possible regardless of the cause of dementia, research relating to the nutritional status of patients with dementia has been conducted almost exclusively in patients diagnosed with AD. This chapter focuses primarily on nutrition as it relates to AD. However, many of the principals regarding the evaluation and treatment of weight loss and malnutrition are applicable in vascular dementia and other causes of dementia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hebert LE, Scherr PA, Beckett LA, Albert MS, et al. Age-specific incidence of Alzheimer’s disease in a community population. JAMA 1995; 273: 1354–1359.

    Article  CAS  Google Scholar 

  2. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer’ s disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998; 88: 1337–1342.

    Article  CAS  Google Scholar 

  3. Leon J, Cheng C, Neumann PJ. Alzheimer’ s disease care: costs and potential savings. Health Aff 1998; 17: 206–216.

    Article  CAS  Google Scholar 

  4. White H, Pieper C, Schmader K, Fillenbaum G. Weight change in Alzheimer’s disease. J Am Geriatr Soc 1996; 44: 265–272.

    CAS  Google Scholar 

  5. Cronnin-Stubbs D, Beckett L, Scherr P, Field T, et al. Weight loss in people with Alzheimer’s disease: a prospective population based analysis. BMJ 1997; 314: 178–179.

    Article  Google Scholar 

  6. Sandman O, Adolsson R, Nygren C, et al. Nutritional status and dietary in take in institutionalized patients with Alzheimer’s disease and multiinfarct dementia. J Am Geriatr Soc 1987; 35: 31–38.

    CAS  Google Scholar 

  7. Singh S, Mulley GP, Losowsky MS. Why are Alzheimer’ s disease patients thin? Age Aging 1988; 17: 21–28.

    Article  CAS  Google Scholar 

  8. Du W, DiLuca C, Growdon JH. Weight loss in Alzheimer’s disease. J Geriatr Psychiatry Neurol 1993; 6: 34–38.

    CAS  Google Scholar 

  9. Wolf-Klein GP, Silerstone FA, Levy AP. Nutritional patterns and weight change in Alzheimer patients. Int Psychogeritr 1992; 4: 103–111.

    Article  CAS  Google Scholar 

  10. Burns A, Marsh A, Bender DA. Dietary intake and clinical, anthropometric and biochemical indices of malnutrition in elderly demented patients and nondemented subjects. Psychol Med 1989; 19: 383–391.

    Article  CAS  Google Scholar 

  11. White H, Pieper C, Schmader K, Fillenbaum G. A longitudinal analysis of weight change in Alzheimer’ s disease. J Am Geriatr Soc 1997; 45: 531–532.

    CAS  Google Scholar 

  12. Renvall MJ, Spindler AA, Nichols JF, Ramsdell JW. Body composition of patients with Alzheimer’s disease. J Am Diet Assoc 1993; 93: 47–52.

    Article  CAS  Google Scholar 

  13. White H, Pieper C, Schmader K. The association of weight change in Alzheimer’ s disease with severity of disease and mortality: A longitudinal analysis. J Am Geriatr Soc 1998; 46: 1223–1227.

    CAS  Google Scholar 

  14. Barrett-Connor E, Edelstein S, Corey-Bloom J, Wiederholt W. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc 1996; 44: 1147–1152.

    CAS  Google Scholar 

  15. Volicer L, Seltzer B, Rheume Y, et al. Eating difficulties in patients with probable dementia of the Alzheimer type. J Geriatr Psych Neurol 1989; 2: 188–195.

    Article  CAS  Google Scholar 

  16. Blandford G, Watkins LB, Mulvihill M, Taylor B. Correlations of aversive feeding behaviors in dementia patients. J Am Geriatr Soc 1995;43:SA10:4.

    Google Scholar 

  17. Athlin E, Norberg A, Asplund K, Jansson L. Feeding problems in severely demented patients seen from task and relational aspects. Scand J Caring Sci 1989; 3: 113–121.

    Article  CAS  Google Scholar 

  18. Norberg A, Athlin E. Eating problems in severely demented patients: Issues and dilemmas. Nurse Clin N Am 1989; 24: 781–788.

    CAS  Google Scholar 

  19. Morris CH, Hope RA, Fairburn CG. Eating habits in dementia. Br J Psych 1989; 154: 801–806.

    Article  CAS  Google Scholar 

  20. Horner J, Alberts MJ, Dawson DV, Cook GM. Swallowing in Alzheimer’s disease. Alzheimer’s Dis Assoc Disorders 1994; 8: 177–189.

    Article  CAS  Google Scholar 

  21. Chouinard J, Lavigne E, Villeneuve C. Weight loss, dysphagia, and outcome in advanced dementia. Dysphagia 1998; 13: 151–155.

    Article  CAS  Google Scholar 

  22. Priefer BA, Robbins J. Eating changes in mild-stage Alzheimer’ s disease: a pilot study. Dysphagia 1997; 12: 212–221.

    Article  CAS  Google Scholar 

  23. Spindler AA, Renvall MJ, Nichols JF, Ramsdell JW. Nutritional status of patients with Alzheimer’ s disease:a 1-year study. J Am Diet Assoc 1996; 96: 1013–1018.

    Article  CAS  Google Scholar 

  24. Renvall MJ, Spindler AA, Ramsdell JW, Paskvan M. Nutritional status of free-living Alzheimer’ s patients. Am J Med Sci 1989; 298: 20–26.

    Article  CAS  Google Scholar 

  25. Burns A, Marsh A, Bender DA. Dietary intake and clinical, anthropometric and biochemical indices of malnutrition in elderly demented patients and nondemented subjects. Psychol Med 1989; 19: 383–391.

    Article  CAS  Google Scholar 

  26. Niskanen L, Piirainen M, Koljonen M, Uusitupa M. Resting energy expenditure in relation to energy intake in patients with Alzheimer’ s disease, multi-infarct dementia and in control women. Age Ageing 1993; 22: 132–137.

    Article  CAS  Google Scholar 

  27. Franzoni S, Frisoni GB, Boffelli S, Rozzini R, Trabucchi M. Good nutritional oral intake is associated with equal survival in demented and nondemented very old patients. J Am Geriatr Soc 1996; 44: 1366–1370.

    CAS  Google Scholar 

  28. Litchford MD, Wakefield LM. Nutrient intakes and energy expenditures of residents with senile dementia of the Alzheimer’ s type. J Am Diet Assoc 1987; 87: 211.

    CAS  Google Scholar 

  29. Stahelin HB, Hofer HO, Vogel M, Held C, Seiler WO. Energy and protein consumption in patients with senile dementia. Gerontology 1983; 29: 145–148.

    Article  CAS  Google Scholar 

  30. Winograd CH. Jacobson DH, Butterfield GE, Cragen E et al. Nutritional intake in patients with senile dementia of the Alzheimer’ s type. Alz Dis Assoc Disorders 1991; 5: 173–180.

    Article  CAS  Google Scholar 

  31. Schoeller DA. How accurate is self reported energy intake? Nutr Rev 1990; 48: 373–379.

    Article  CAS  Google Scholar 

  32. Goudsmit E, Hofman MA, Fliers E, Swaab DF. The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age, and Alzheimer’ s disease. Neurobiol Aging 1990; 11: 529–536.

    Article  CAS  Google Scholar 

  33. van de Nes JAP, Kamphorst W, Ravid R, Swaab DF. The distribution of Alz-50 immunoreactivity in the hypothalamus and adjoining areas of Alzheimer’ s disease patients. Brain 1993; 116: 103–115.

    Google Scholar 

  34. Swaab DF, Grundke-Iqbal I, Iqbal K, et al. ti and ubiquitin in the human hypothalamus in aging and Alzheimer’s disease. Brain Res 1992; 590: 239–249.

    Article  CAS  Google Scholar 

  35. Schiffman SS, Pasternak M. Decreased discrimination of food odors in the elderly. J Gerontol 1979; 34: 73–79.

    Article  CAS  Google Scholar 

  36. Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection deficits in Alzheimer’ s disease. Brain Res Bull 1987; 18: 597–600.

    Article  CAS  Google Scholar 

  37. Schiffman S, Taste and smell losses in normal aging and disease. JAMA 1997; 278: 1357–1362.

    Article  CAS  Google Scholar 

  38. Schiffman S, Clark C, Warwick Z. Gustatory and olfactory dysfunction in dementia: not specific to Alzheimer’ s disease. Neurobiol Aging 1990; 11: 597–600.

    Article  CAS  Google Scholar 

  39. Serby M, Larson P, Kalkstein D. The nature and course of olfactory deficits in Alzheimer’ s disease. Am J Psychiat 1991; 148: 357–360.

    CAS  Google Scholar 

  40. Koss E, Weiffenbach J, Haxby J, Friedland R. Olfactory detection and identification performance are dissociated in early Alzheimer’s diease. Neurology 1988; 38: 1228–1232.

    Article  CAS  Google Scholar 

  41. Bacon A, Bondi M, Salmon D, Murphy C. Very early changes in olfactory function due to Alzheimer’s disease and the role of apolipoprotein E in olfaction. Ann NY Acad Sci 1998; 855: 723–731.

    Article  CAS  Google Scholar 

  42. Murphy C, Bacon A, Bondi M, Salmon D. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. Ann NY Acad Sci 1998; 855: 744–750.

    Article  CAS  Google Scholar 

  43. Murphy C, Gilmore MM, Seery CS, Salmon DP, Lasker BR. Olfactory thresholds are associated with degree of dementia in Alzheimer’s disease. Neurobiol Aging 1990; 11: 465–469.

    Article  CAS  Google Scholar 

  44. Nordin S, Monsch AU, Murphy C. Unawareness of smell loss in normal aging and Alzheimer’ s disease: discrepancy between self-reported and diagnosed smell sensitivity. J Gerontol 1995; 50B: P187 - P192.

    CAS  Google Scholar 

  45. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer’ s disease. Neurobiol Aging 1991; 12: 295–312.

    Article  CAS  Google Scholar 

  46. Mesholam R, Moberg P, Mahr R, Doty R. Olfaction in neurodegenerative disease: a meta-analysis of olfactory function in Alzheimer’s disease and Parkinson’s disease. Arch Neurol 1998; 55: 84–90.

    Article  CAS  Google Scholar 

  47. Inuii A. Cancer anorexia-cachexia syndrome: Are neuropeptides the key? Cancer Res 1999; 59: 4493–4510.

    Google Scholar 

  48. Berry C. Clark AL. Catabolism in chronic heart failure. Eur Heart J 2000; 21: 521–532.

    Article  CAS  Google Scholar 

  49. Cohen HJ, Pieper CF, Harris T, Rao MK, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol: Med Sci 1997; 52A: M201 - M208.

    Article  CAS  Google Scholar 

  50. Dentino AN, Pieper CF, Rao KMK, et al. Association of Interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc 1999; 47: 6–11.

    CAS  Google Scholar 

  51. Griffin WS, Sheng JG, Roberts GW, Mrak RE. Interleukin-1 expression in different plaque types in Alzheimer’ s disease: significance in plaque evolution. J Neuropathol Exp Neurol 1995; 54: 276–281.

    Article  CAS  Google Scholar 

  52. Griffin WS, Sheng JG, Royston MC, et al. Glial-neuronal interactions in Alzheimer’s disease: the potential role of a ‘cytokine cycle’ in disease progression. Brain Pathol 1998; 8: 65–72.

    Article  CAS  Google Scholar 

  53. Ringheim GE, Szczepanik AM, Petko W, et al. Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex. Mol Brain Res 1998; 55: 35–44.

    Article  CAS  Google Scholar 

  54. Bauer J, Strauss S, Schreiter-Gasser U, et al. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer’s disease cortices. FEBS Lett 1991; 285: 111–114.

    Article  CAS  Google Scholar 

  55. Hull M, Berger M, Volk B, Bauer J. Occurrence of interleukin-6 in cortical plaques of Alzheimer’s disease patients may precede transformation of diffuse into neuritic plaques. Ann NY Acad Sci 1996; 777: 205–212.

    Article  CAS  Google Scholar 

  56. Rogers I. Neuroinflammatory Mechanisms in Alzheimer’s Disease. Birkhaüser, Basel, 2001.

    Book  Google Scholar 

  57. Papassotiropoulos A, Bagli M, Jessen F, Bayer TA, et al. A genetic variation of the inflammatory cytokine interleukin-6 delays the intial onset and reduces the risk for sporadic Alzheimer’ s disease. Ann Neurol 1999; 45: 666–668.

    Article  CAS  Google Scholar 

  58. Licastro F, Pedrini S, Caputo L, et al. Increased plasma levels of interleukin-1, interleukin-6 and alpha1-antichymotrypsin in patients with Alzheimer’ s disease: peripheral inflammation or signals from the brain? J Neuroimmunol 2000; 103: 97–102.

    Article  CAS  Google Scholar 

  59. Maes M, DeVos N, Wauters A, Demedts P, Maurits VW, Neels H, et al. Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer’ s disease. J Psychiatr Res 1999; 33: 397–405.

    Article  CAS  Google Scholar 

  60. Bonaccorso S, Lin A, Song C, et al. Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer’ s disease (DAT): lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT. Aging (Milano) 1998; 10: 316–323.

    CAS  Google Scholar 

  61. Singh VK, Guthikonda P.Circulating cytokines in Alzheimer’ s disease. J Psychiatr Res 1997; 31: 657–660.

    Article  CAS  Google Scholar 

  62. Kalman J, Juhasz A, Laird G, et al. Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer’s disease. Acta Neurologica Scandinavica 1997; 96: 236–240.

    Article  CAS  Google Scholar 

  63. Licastro F, Morini MC, Polazzi E, Davis LJ. Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer’ s disease: an acute phase reactant without the peripheral acute phase response. J Neuroimmunol 1995; 57: 71–75.

    Article  CAS  Google Scholar 

  64. Fillit H, Ding WH, Buee L, et al. Elevated circulating tumor necrosis factor levels in Alzheimer’s disease. Neurosci Lett 1991; 129: 318–320.

    Article  CAS  Google Scholar 

  65. Shalit F, Sredni B, Stern L, Kott E, Huberman M. Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer’s patients. Neurosci Lett 1994; 174: 130–132.

    Article  CAS  Google Scholar 

  66. Lombardi VR, Garcia M, Rey L, Cacabelos R. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer’ s Disease (AD) individuals. J Neuroimmunol 1999; 97: 163–171.

    Article  CAS  Google Scholar 

  67. Angelis P, Scharf S, Mander A, Vajda F, Christophidis N. Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer’s disease. Neurosci Lett 1998; 244: 106–108.

    Article  CAS  Google Scholar 

  68. Pirttila T, MehtaPD, Frey H, Wisniewski HM. Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer’s disease. Neurobiol Aging 1994; 15: 313–317.

    Article  CAS  Google Scholar 

  69. Esumi E, Araga S, Takahashi K. Serum interleukin-2 levels in patients with dementia of the Alzheimer type. Acta Neurologica Scandinavica 1991; 84: 65–67.

    Article  CAS  Google Scholar 

  70. van Duijn CM, Hofman A, Nagelkerken L. Serum levels of interleukin-6 are not elevated in patients with Alzheimer’s disease. Neurosci Lett 1990; 108: 350–354.

    Google Scholar 

  71. Poehlman ET. Regulation of energy expenditure in aging humans. J Am Geriatr Soc 1993; 41: 552–559.

    CAS  Google Scholar 

  72. Donaldson KE, Carpenter WH, Toth MJ, et al. No evidence for a higher resting metabolic rate in non-institutionalized Alzheimer’s patients. J Am Geriatr Soc 1996; 44: 1232–1234.

    CAS  Google Scholar 

  73. Niskanen L, Piirainen M, Koljonen M, Uusitupa M. Resting energy expenditure in relation to energy intake in patients with Alzheimer’ s disease, multiinfarct dementia and in control women. Age Aging 1993; 22: 132–137.

    Article  CAS  Google Scholar 

  74. Wolf-Klein GP, Silerstone FA, Lansey SC, et al. Energy requirements in Alzheimer’ s disease patients. Nutrition 1995; 11: 264–268.

    CAS  Google Scholar 

  75. Poehlman ET, Toth MJ, Goran MI, Carpenter WH, Newhouse P, Rosen CJ. Daily energy expenditure in free-living non-institutionalized Alzheimer’s patients: a doubly labeled water study. Neurology 1997; 48: 997–1002.

    Article  CAS  Google Scholar 

  76. Gillete-Guyonnet S, Nourhashemi F, Andrieu S, deGlisezinski I, Ousset PJ, Riviere D, et al. Weight Loss in Alzheimer’s disease. Am J Clin Nutr 2000; 71 (suppl): 637S - 642S.

    Google Scholar 

  77. White HK, McConnell ES, Bales CW, Kuchibbahtia M. A 6-month observational study of the relationship between weight loss and behavioral symptoms in institutionalized AD subjects. J Am Geriatr Soc 2001; 49: 544.

    Google Scholar 

  78. Smith MA, Perry G, Richey PL, et al. Oxidative damage in Alzheimer’s. Nature 1996; 382: 120–121.

    Article  CAS  Google Scholar 

  79. Jaendel C, Nicolas MB, Dubois F, et al. Lipid peroxidation and free radical scavengers in Alzheimer’s disease. Gerontology 1989; 35: 275–282.

    Article  Google Scholar 

  80. Commenges D, Scotet V, Renaud S, et al. Intake of flavinoids and risk of dementia. Eur J Epidem 2000; 16: 357–363.

    Article  CAS  Google Scholar 

  81. Halliwell B, Gutteridge JMC. Oxygen radicals in the nervous system. Trends Neurosci 1985; 8: 22–26.

    Article  CAS  Google Scholar 

  82. Sano M, Ernesto C, Thomas RG Klauber MR, et al. A controlled trial of selegiline, alpha-tocopheral, or both as treatment for Alzheimer’s disease. N Eng J Med 1997; 336: 1216–1222.

    Article  CAS  Google Scholar 

  83. Hector M, Burton JR, What are the psychiatric manifestations of B12 deficiency? J Am Geriatr Soc 1988; 36: 1105–1112.

    CAS  Google Scholar 

  84. Lindenbaum J, Healton EB, Savage DG et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Eng J Med 1988; 318: 1720–1728.

    Article  CAS  Google Scholar 

  85. Martin DC, Francis j, Protetchj et al. Time dependency of cogntive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 1992; 40: 168–172.

    CAS  Google Scholar 

  86. Ikeda T, Furukawa Y, Nashimoto S, et al. Vitamin B12 levels inserum and cerobrospinal fluid of people with Alzheimer’s disease. Acta Psychiatr Scand 1990; 82: 327–329.

    Article  CAS  Google Scholar 

  87. Basun H, Forsell LG, Bendz R et al. Cobalamin in blood and cerebrospinal fluid in Alzheimer’ s disease and related disorders. Dementia 1991; 2: 324–332.

    Google Scholar 

  88. Basun H, Fratiglioni L, Winblad B. Cobalamin levels are not reduced in Alzheimer’s disease: results from a population-based study. J Am Geriatr Soc 1994; 42: 132–136.

    CAS  Google Scholar 

  89. Carmel R, Gott PS, Waters CH et al. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. EurJ Haemat 1995; 54: 245–253.

    Article  CAS  Google Scholar 

  90. Teunisse S, Bollen AE, van Gool WA, Walstra GJ. Dementia and subnormal levels of vitamin B12: effects of replacement therapy on dementia. J Neurol 1996; 243: 522–529.

    Google Scholar 

  91. Crystal HA, Ortof E, Frishman WH et al. Serum vitamin B12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx longitudinal aging study. J Am Geriatr S oc 1994; 42: 933–936.

    CAS  Google Scholar 

  92. Clark R, Smith AD, Jobst KA et al. Folate, vitamin B12 and serum total homocysteine levels in confirmed Alzheimer’s disease. Arch Neurol 1998; 55: 1407–1408.

    Article  Google Scholar 

  93. Seshadri S, Beiser A, Selhub J, Jacques P et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Eng J Med 2002; 346: 476–483.

    Article  CAS  Google Scholar 

  94. Loscalzo J. Homocysteine and dementias. N Eng J Med 2002; 346: 466–468.

    Article  Google Scholar 

  95. Rogers SL, Farlow MR, Doody RS, et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease. Neurology 1998; 50: 136–145.

    Article  CAS  Google Scholar 

  96. RoslerM, Anand R, Cicin-Sain A, Gauthier S, et al. Efficacy and safety of rivastigmine in patients with Alzheimer’ s disease: international randomized controlled trial. BMJ 1999; 318: 633–640.

    Google Scholar 

  97. Tariot PN, Solomon PR, Morris JC, Kershaw P, et al. A 5-month, randomized, placebo-controlled trial of galatamine in AD. Neurology 2000; 54: 2269 2276.

    Google Scholar 

  98. Rasking MA, Peskind ER, Wessel T, Yuan W et al. Galantamine in AD: a 6-month randomized, placebo-controlled trial with a 6-month extension. Neurology 2000; 54: 2261–2268.

    Article  Google Scholar 

  99. Lauque S, Wegner A, Ous set PJ, et al. Comparative study on nutritional intake and cognitive functions (WAIS code). Age Nutr 1995; 6: 68–72 (in French).

    Google Scholar 

  100. LaRue A, Koehler KM, Wayne SJ, Chiulli SJ, Haaland KY, Garry PJ. Nutritional status and cognitive functioning in normally aging sample:a 6-year reassessment. Am J Clin Nutr 1997; 65: 20–29.

    CAS  Google Scholar 

  101. Perrig WJ, Perrig P, Stehelin B. The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc 1997; 45: 718–724.

    CAS  Google Scholar 

  102. Ortega RM, Requejo AM, Andres P, et al. Dietary intake and cognitive function in a group of elderly people Am J Clin Nutr 1997; 66: 803–809.

    CAS  Google Scholar 

  103. Goodwin JS, Goodwin JM, Garry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983; 249: 2917–2921.

    Article  CAS  Google Scholar 

  104. Rivière S, Gillette-Guyonnet S, Voisin T, et al. A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer’ s Disease. J Nutr Health Aging 2001; 5: 295–299.

    Google Scholar 

  105. Tayback M, Kumanyika S, Chee E. Body weight as a risk factor in the elderly. Arch Intern Med 1990; 150: 1065–1072.

    Article  CAS  Google Scholar 

  106. Tully CL, Snowdon DA. Weight change and physical function in older women: findings from the nun study. J Am Geriatr Soc 1995; 43: 1394–1397.

    CAS  Google Scholar 

  107. Stevens J, Cai J, Pamuk E, Williamson D, Thun M, Wood J. The effect of age on the association between body-mass index and mortality. N Eng J Med 1998; 338: 1–7.

    Article  CAS  Google Scholar 

  108. Payette H, Coulombe C, Boutier V, Gray-Donald K. Weight loss and mortality among free-living frail elders: a prospective study. J Gerontol 1999; 54A: M440 - M445.

    Article  CAS  Google Scholar 

  109. Keller HH. Weight gain impacts morbidity and mortality in institutionalized oler persons. J Am Geriatr Soc 1995; 43: 165–169.

    CAS  Google Scholar 

  110. Soltesz KS, Dayton JH. Finger foods help those with Alzheimer’s maintain weight. J Am Diet Assoc 1993; 93: 1106–1108.

    Article  CAS  Google Scholar 

  111. Winograd CH, Brown EM. Aggressive oral refeeding in hosptitalized patients. Am J Clin Nutr 1990; 52: 967–968.

    CAS  Google Scholar 

  112. Finucane TE, Christmas C, Travis K. Tube feeding in patients with advanced dementia: a review of the evidence. JAMA 1999; 282: 1365–1370.

    Article  CAS  Google Scholar 

  113. Lazarus BA, Murphy JB, Culpeper L. Aspiration associated with long-term gastric versus jejunal feeding: a critical analysis of the literature. Arch Phys Med Rehabil 1990; 71: 46–53

    CAS  Google Scholar 

  114. Fox KA, Mularski RA, Sarfati MR, et al. Aspiration pneumonia following surgically placed feeding tubes. Am J Surg 1995; 170: 564–566.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Heidi K. White
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Durham VA Medical Center and Duke University Medical Center, Durham, NC, USA

    Connie Watkins Bales PhD, RD, FACN

  2. Louisville VA Medical Center and University of Louisville Schools of Medicine and Public Health, Louisville, KY, USA

    Christine Seel Ritchie MD, MSPH

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

White, H.K. (2004). Dementia. In: Bales, C.W., Ritchie, C.S. (eds) Handbook of Clinical Nutrition and Aging. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-391-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-391-0_13

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5355-4

  • Online ISBN: 978-1-59259-391-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation